Skip to main content

Table 3 Adverse events

From: Blind bedside postpyloric placement of spiral tube as rescue therapy in critically ill patients: a prospective, tricentric, observational study

Events, number (percentage)

Value in total study sample (n = 127)

Any event

33 (26.0)

MATEs

29 (22.8)

 Vital signs alert eventsa

15 (11.8)

 Requirement of sedatives or analgesics during procedure

14 (11.2)

 Nausea

8 (6.3)

 Pain

6 (4.7)

 Nasal mucosa bleeding

5 (3.9)

 Vomiting

3 (2.4)

Metoclopramide-associated events

5 (4.0)

 Amyostasia

2 (1.6)

 Lethargy

1 (0.8)

 Dysphoria

1 (0.8)

 Xerostomia

1 (0.8)

  1. Qualitative variables are presented as number (percentage)
  2. MATEs major adverse tube-associated events
  3. aDefined as any vital sign that fluctuated beyond the range of ± 15%, or pulse oxygen saturation that declined to < 90%